USFDA inspects Shilpa Medicare’s bio-analytical laboratory in Hyderabad
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The facility will accommodate over 1,500 employees
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
The Vice President also highlighted the importance of preventive healthcare and fitness
Subscribe To Our Newsletter & Stay Updated